SLC3A2 and neoplasm: When aberrantly expressed, LAT1-4F2hc mediates the uptake of leucine and tunes the growth of tumour cells through the mechanistic target of rapamycin (mTOR) pathway, implicating the transporter in several human malignancies2,8.